Skip to main content
Clinical Trials/ACTRN12608000176369
ACTRN12608000176369
Not yet recruiting
未知

A prospective study to examine the effectiveness and safety of neuraminidase inhibitors in index cases with presumed pandemic influenza infection

ational Centre in HIV Epidemiology and Clinical Research (NCHECR)0 sites1,000 target enrollmentApril 9, 2008

Overview

Phase
未知
Intervention
Not specified
Conditions
Pandemic influenza
Sponsor
ational Centre in HIV Epidemiology and Clinical Research (NCHECR)
Enrollment
1000
Status
Not yet recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 9, 2008
End Date
TBD
Last Updated
6 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
ational Centre in HIV Epidemiology and Clinical Research (NCHECR)

Eligibility Criteria

Inclusion Criteria

  • 1\. Clinical diagnosis of pandemic influenza (consistent with the applicable clinical case definition)
  • 2\. Provision of written informed consent or equivalent
  • 3\. Intention to commence treatment with a neuraminidase inhibitor

Exclusion Criteria

  • There are no exclusion criteria.

Outcomes

Primary Outcomes

Not specified

Similar Trials